And another one, in fact the very one you mention, Wilder. BLUE HP's cup runneth over!
>>BOTHELL, Wash.--(BW HealthWire)--Dec. 14, 2001--Northwest Biotherapeutics, Inc. (Nasdaq:NWBT - news) today announced that it commenced its initial public offering of 4,000,000 shares of its common stock at a price of $5 per share.
The public offering was led by C.E. Unterberg, Towbin, with Fahnestock & Co. Inc. and Roth Capital Partners, LLC as co-managers.
All of the shares were sold by the Company. The Company has granted the underwriters an option to purchase an additional 600,000 shares solely to cover over-allotments, if any. The Company's common stock will be traded on the Nasdaq National Market under the symbol ``NWBT.''
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing and commercializing immunotherapy products that safely generate and enhance immune system responses to effectively treat cancer. The Company combines its expertise in dendritic cell biology, immunology and antigen discovery with its proprietary technologies to develop cancer therapies.
The Company's development efforts are based on two versatile product development programs - DCVax(TM), a dendritic cell-based immunotherapy platform and HuRx(TM), a fully human monoclonal antibody platform.
The Company's lead DCVax product candidate, DCVAX-Prostate, is a prostate cancer treatment for which the Company is commencing a Phase III clinical trial. HuRx(TM) is a fully human monoclonal antibody program that is being co-developed with Medarex, Inc. The Company's lead HuRx(TM) product candidate, HuRx-Prostate, is currently being manufactured for anticipated Phase I clinical trials.
Copies of the prospectus relating to the underwritten public offering may be obtained from C.E. Unterberg, Towbin, 350 Madison Avenue, New York, New York 10017, Attn: Prospectus Department.
nwbio.com
--------------------------------------------------------------------------------
Contact:
Northwest Biotherapeutics, Inc., Bothell
Mary Royals, 202/778-1021
mroyals@apcoassoc.com<<
snip
Cheers, Tuck |
